Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)

Clinical trial NCT00989261 · COMPLETED

Trial details

NCT number: NCT00989261
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2009-11-01
Primary completion: 2012-09-28
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.